Flexion Therapeutics, Inc. (FLXN): $6.50

0.71 (+12.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Flexion Therapeutics Inc (FLXN) Price Targets From Analysts

Use the tables below to see what analysts covering Flexion Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
12 $35 $8 $19.25 $6.61 191.23%

The Trend in the Analyst Price Target


Over the past 26 weeks, FLXN's average price target has gone down $0.33.

FLXN reports an average of 93.76% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 12 35 8 19.25 6.71 186.89%
2021-07-10 12 35 8 19.25 7.82 146.16%
2021-06-21 13 35 8 19.15 9.15 109.29%
2021-06-13 13 35 8 19.15 9.30 105.91%
2021-06-05 13 35 8 19.15 8.49 125.56%
2021-04-26 13 35 11 19.77 8.66 128.29%
2021-04-25 13 35 11 19.77 8.16 142.28%
2021-04-17 13 35 11 19.77 9.41 110.1%
2021-03-23 13 35 15 20.38 9.74 109.24%
2021-03-20 13 35 15 20.38 10.18 100.2%
2021-03-13 13 35 15 20.38 11.84 72.13%
2021-02-01 12 35 15 20.17 12.95 55.75%
2021-01-30 13 35 15 20.69 12.17 70.01%
2021-01-23 13 35 16 20.77 11.54 79.98%
2021-01-16 12 27 16 19.58 13.06 49.92%
2021-01-09 11 25 16 18.91 12.32 53.49%
2020-11-26 13 35 16 20.77 10.84 91.61%
2020-11-14 12 35 16 20.50 11.38 80.14%
2020-10-16 12 35 15 20.58 13.42 53.35%
2020-09-27 12 35 15 20.67 11.02 87.57%
2020-08-31 12 35 15 20.67 11.66 77.27%
2020-08-19 12 35 15 20.75 12.65 64.03%
2020-07-29 11 35 17 21.27 13.52 57.32%
2020-07-22 9 35 17 21.78 NA NA%
2020-07-14 9 35 17 21.78 NA NA%
2020-07-11 9 35 17 21.89 NA NA%
2020-06-24 9 35 17 21.89 NA NA%
2020-06-15 8 35 17 21.50 NA NA%
2020-05-22 8 35 17 21.50 NA NA%

FLXN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.42 3 8 1 0 0 12

The Trend in the Broker Recommendations


Over the past 48 weeks, FLXN's average broker recommendation rating worsened by 0.83.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FLXN as an investment opportunity.

  • Flexion Therapeutics Inc's variance in analysts' estimates is lower than 1.41% of all US stocks.
  • FLXN has a higher number of analysts covering the stock than 99.43% of stocks in the small market cap category.
  • Flexion Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 90.82% of all US stocks.
  • Flexion Therapeutics Inc's average analyst price target is greater than 35.99% of all US stocks.

Stocks similar to Flexion Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VKTX, CBAY and AVRO.

What is the outlook for FLXN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7374 seconds.